Baloxavir marboxil
- Pengantar
- Produk Terbaru
Pengantar
Baloxavir marboxil
Baloxavir Marboxil was first approved for use in Japan in February 2018 and later by the FDA in October for the treatment of acute uncomplicated influenza in patients 12 years of age and older who have been symptomatic for no more than 48 hoursBaloxavir marboxil adalah inhibitor cap-endonuclease, yang memiliki mekanisme aksi yang unik untuk Menghambat proliferasi virus influenza.
Produk Terbaru
| Gambar | Bagian # | Deskripsi | produsen | Stok | RFQ | |
|---|---|---|---|---|---|---|
|
|
Baloxavir marboxil (1985606-14-1) |
CAS: 1985606-14-1;Pembuat Baloxavir; Baloxavir API; Anti-Viral
|
|
Persediaan
|
|
|
|
|
7- (Benzyloxy)-3,4,12,12a-tetrahidro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione (1370250-39-7) |
CAS: 1370250-39-7; Baloxavir produsen; Baloxavir perantara; Anti-Viral
|
|
Persediaan
|
|
|
|
|
(R)-7- ((benzyloxy) - 3,4,12,12a-tetrahidro- 1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]- triazine-6,8-dione (1985607-70-2) |
CAS: 1985607-70-2; CAS: 1985607-70-2; Baloxavir manufacturer; Produsen Balox
|
|
Persediaan
|
|
|
|
|
7,8-difluoro-6,11-dihydro-Dibenzo[b,e]thiepin-11-ol (1985607-83-7) |
CAS: 1985607-83-7; CAS: 1985607-83-7; Baloxavir manufacturer; Produsen Balox
|
|
Persediaan
|
|
